Viveve Medical Stock Cash Flow From Operations
| VIVEDelisted Stock | USD 0.1 0.0005 0.53% |
Viveve Medical fundamentals help investors to digest information that contributes to Viveve Medical's financial success or failures. It also enables traders to predict the movement of Viveve Pink Sheet. The fundamental analysis module provides a way to measure Viveve Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Viveve Medical pink sheet.
Viveve |
Viveve Medical Company Cash Flow From Operations Analysis
Viveve Medical's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Viveve Medical Cash Flow From Operations | (12.88 M) |
Most of Viveve Medical's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Viveve Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, Viveve Medical has (12.88 Million) in Cash Flow From Operations. This is 102.44% lower than that of the Health Care Equipment & Supplies sector and 103.52% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 101.33% higher than that of the company.
Viveve Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Viveve Medical's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Viveve Medical could also be used in its relative valuation, which is a method of valuing Viveve Medical by comparing valuation metrics of similar companies.Viveve Medical is currently under evaluation in cash flow from operations category among its peers.
Viveve Fundamentals
| Return On Equity | -2.11 | ||||
| Return On Asset | -0.62 | ||||
| Operating Margin | (3.10) % | ||||
| Current Valuation | 4.26 M | ||||
| Shares Outstanding | 10.72 M | ||||
| Shares Owned By Institutions | 5.21 % | ||||
| Number Of Shares Shorted | 374.24 K | ||||
| Price To Earning | (2.59) X | ||||
| Price To Book | 3.62 X | ||||
| Price To Sales | 0.66 X | ||||
| Revenue | 6.43 M | ||||
| Gross Profit | 620 K | ||||
| EBITDA | (19.89 M) | ||||
| Net Income | (22.03 M) | ||||
| Cash And Equivalents | 9.43 M | ||||
| Cash Per Share | 0.88 X | ||||
| Total Debt | 5.12 M | ||||
| Debt To Equity | 1.12 % | ||||
| Current Ratio | 1.32 X | ||||
| Book Value Per Share | 0.11 X | ||||
| Cash Flow From Operations | (12.88 M) | ||||
| Short Ratio | 4.15 X | ||||
| Earnings Per Share | (2.55) X | ||||
| Price To Earnings To Growth | (0.13) X | ||||
| Target Price | 3.1 | ||||
| Number Of Employees | 47 | ||||
| Beta | 0.37 | ||||
| Market Capitalization | 1.08 M | ||||
| Total Asset | 25.91 M | ||||
| Retained Earnings | (68.62 M) | ||||
| Working Capital | 13.21 M | ||||
| Current Asset | 18.53 M | ||||
| Current Liabilities | 5.32 M | ||||
| Z Score | -2.8 | ||||
| Net Asset | 25.91 M |
About Viveve Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Viveve Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Viveve Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Viveve Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Viveve Pink Sheet
If you are still planning to invest in Viveve Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viveve Medical's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |